Tapewire

Nasdaq · USD

CRSP

CRISPR Therapeutics AG

Export transactions ↓
Tapewire entity
3852
SEC CIK
0001674416
Parsed reports
491

Last 12 months

Inside the activity.

0 purchase rows · 27 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202503
Jan 202607
Feb 202602
Mar 2026010
Apr 202600
May 202601
Jun 202600
Jul 202600
Aug 202600
Sep 202602
Oct 202602

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 10, 2024 Filed Mar 12, 2024 21:45 UTC
Kulkarni SamarthDirector · Chief Executive Officer
Exercise / conversionRestricted Stock Units · Derivative 19,250 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-24-030189 · ownership.xml · derivative · entry 6

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,750

Underlying: Common Shares · 19,250 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

F3 · derivative.exercise_date: This restricted stock unit award was granted on March 10, 2023 with respect to 77,000 Common Shares, with (i) one quarter of the shares vesting on March 10, 2024, (ii) one quarter of the shares vesting on March 10, 2025, (iii) one quarter of the shares vesting on March 10, 2026, and (iv) one quarter of the shares vesting on March 10, 2027.

F3 · derivative.expiration_date: This restricted stock unit award was granted on March 10, 2023 with respect to 77,000 Common Shares, with (i) one quarter of the shares vesting on March 10, 2024, (ii) one quarter of the shares vesting on March 10, 2025, (iii) one quarter of the shares vesting on March 10, 2026, and (iv) one quarter of the shares vesting on March 10, 2027.

Read SEC document
March 10, 2024 Filed Mar 12, 2024 21:45 UTC
Kulkarni SamarthDirector · Chief Executive Officer
Exercise / conversionCommon Shares 19,250 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-24-030189 · ownership.xml · nonDerivative · entry 1

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 213,507

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

Read SEC document
February 27, 2024 Filed Feb 27, 2024 23:39 UTC GrantCommon Shares 769,196 $71.50 $54,997,514.00
Disclosure

SEC source: 0000950170-24-021510 · ownership.xml · nonDerivative · entry 3

George Simeon · CIK 0001595117 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See Note 3

Disclosed balance after: 769,196

F3 · ownership.nature: The Reporting Person is the sole managing member of SR One Capital Management, which is the sole general partner of SR One Capital SMA Partners, LP ("SMA Partners"). SMA Partners is the sole general partner of AMZL, LP ("AMZL"), which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 or otherwise of such portion of the securities held by AMZL in which the Reporting Person has no pecuniary interest.

Read SEC document
February 27, 2024 Filed Feb 27, 2024 23:39 UTC GrantCommon Shares 216,578 $71.50 $15,485,327.00
Disclosure

SEC source: 0000950170-24-021510 · ownership.xml · nonDerivative · entry 2

George Simeon · CIK 0001595117 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See Note 2

Disclosed balance after: 216,578

F2 · ownership.nature: The Reporting Person is the sole managing member of SR One Capital Management, which is the sole general partner of SR One Capital Opportunities Partners I, LP ("SR One Opportunities Partners I"). SR One Opportunities Partners I is the sole general partner of SR One Capital Opportunities Fund I, LP ("SR One Opportunities Fund I"), which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 or otherwise of such portion of the securities held by SR One Opportunities Fund I in which the Reporting Person has no pecuniary interest.

Read SEC document
February 27, 2024 Filed Feb 27, 2024 23:39 UTC GrantCommon Shares 63,177 $71.50 $4,517,155.50
Disclosure

SEC source: 0000950170-24-021510 · ownership.xml · nonDerivative · entry 1

George Simeon · CIK 0001595117 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See Note 1

Disclosed balance after: 63,177

F1 · ownership.nature: The Reporting Person is the sole managing member of SR One Capital Management, LLC ("SR One Capital Management"), which is the sole general partner of SR One Capital Partners II, LP ("SR One Partners II"). SR One Partners II is the sole general partner of SR One Capital Fund II Aggregator, LP ("SR One Fund II Aggregator"), which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended ("Section 16"), or otherwise of such portion of the securities held by SR One Fund II Aggregator in which the Reporting Person has no pecuniary interest.

Read SEC document
February 20, 2024 Filed Feb 21, 2024 22:45 UTC
KASINGER JAMES R.General Counsel and Secretary
SaleCommon Shares 1,913 $79.67 $152,408.71
Disclosure

SEC source: 0000950170-24-018175 · ownership.xml · nonDerivative · entry 2

KASINGER JAMES R. · CIK 0001708172 · General Counsel and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,371

F3 · shares: Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person.

Read SEC document
February 20, 2024 Filed Feb 21, 2024 22:45 UTC
Kulkarni SamarthDirector · Chief Executive Officer
SaleCommon Shares 6,370 $79.67 $507,497.90
Disclosure

SEC source: 0000950170-24-018174 · ownership.xml · nonDerivative · entry 2

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 194,257

F2 · shares: Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person.

Read SEC document
February 18, 2024 Filed Feb 21, 2024 22:45 UTC
KASINGER JAMES R.General Counsel and Secretary
Exercise / conversionRestricted Stock Units · Derivative 3,825 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-24-018175 · ownership.xml · derivative · entry 3

KASINGER JAMES R. · CIK 0001708172 · General Counsel and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,650

Underlying: Common Shares · 3,825 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

F4 · derivative.exercise_date: This restricted stock unit award was granted on February 18, 2022 with respect to 15,300 Common Shares, with (i) one quarter of the shares vesting on February 18, 2023, (ii) one quarter of the shares vesting on February 18, 2024, (iii) one quarter of the shares vesting on February 18, 2025, and (iv) one quarter of the shares vesting on February 18, 2026.

F4 · derivative.expiration_date: This restricted stock unit award was granted on February 18, 2022 with respect to 15,300 Common Shares, with (i) one quarter of the shares vesting on February 18, 2023, (ii) one quarter of the shares vesting on February 18, 2024, (iii) one quarter of the shares vesting on February 18, 2025, and (iv) one quarter of the shares vesting on February 18, 2026.

Read SEC document
February 18, 2024 Filed Feb 21, 2024 22:45 UTC
KASINGER JAMES R.General Counsel and Secretary
Exercise / conversionCommon Shares 3,825 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-24-018175 · ownership.xml · nonDerivative · entry 1

KASINGER JAMES R. · CIK 0001708172 · General Counsel and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,284

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

F2 · balance_after: Includes 615 shares acquired under the CRISPR Therapeutics AG 2016 Employee Stock Purchase Plan.

Read SEC document
February 18, 2024 Filed Feb 21, 2024 22:45 UTC
Kulkarni SamarthDirector · Chief Executive Officer
Exercise / conversionRestricted Stock Units · Derivative 13,250 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-24-018174 · ownership.xml · derivative · entry 4

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,500

Underlying: Common Shares · 13,250 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

F3 · derivative.exercise_date: This restricted stock unit award was granted on February 18, 2022 with respect to 53,000 Common Shares, with (i) one quarter of the shares vesting on February 18, 2023, (ii) one quarter of the shares vesting on February 18, 2024, (iii) one quarter of the shares vesting on February 18, 2025, and (iv) one quarter of the shares vesting on February 18, 2026.

F3 · derivative.expiration_date: This restricted stock unit award was granted on February 18, 2022 with respect to 53,000 Common Shares, with (i) one quarter of the shares vesting on February 18, 2023, (ii) one quarter of the shares vesting on February 18, 2024, (iii) one quarter of the shares vesting on February 18, 2025, and (iv) one quarter of the shares vesting on February 18, 2026.

Read SEC document
February 18, 2024 Filed Feb 21, 2024 22:45 UTC
Kulkarni SamarthDirector · Chief Executive Officer
Exercise / conversionCommon Shares 13,250 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-24-018174 · ownership.xml · nonDerivative · entry 1

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 200,627

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

Read SEC document
February 15, 2024 Filed Feb 16, 2024 22:45 UTC
Kulkarni SamarthDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 20,000 $0.00 Strike: $19.12 $0.00
Disclosure

SEC source: 0000950170-24-016574 · ownership.xml · derivative · entry 6

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 39,582

Underlying: Common Shares · 20,000 shares

Expires 2027-12-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: This option was granted on December 1, 2017 with respect to 260,000 Common Shares with 100% of the shares vesting in 48 equal monthly installments beginning January 1, 2018.

Read SEC document
February 15, 2024 Filed Feb 16, 2024 22:45 UTC
Kulkarni SamarthDirector · Chief Executive Officer
SaleCommon Shares 1,100 $81.66 $89,830.95
Disclosure

SEC source: 0000950170-24-016574 · ownership.xml · nonDerivative · entry 4

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 187,377

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2023

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.55 to $81.78, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
February 15, 2024 Filed Feb 16, 2024 22:45 UTC
Kulkarni SamarthDirector · Chief Executive Officer
SaleCommon Shares 5,951 $81.04 $482,256.54
Disclosure

SEC source: 0000950170-24-016574 · ownership.xml · nonDerivative · entry 3

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 188,477

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2023

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.55 to $81.53, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
February 15, 2024 Filed Feb 16, 2024 22:45 UTC
Kulkarni SamarthDirector · Chief Executive Officer
SaleCommon Shares 12,949 $79.94 $1,035,089.97
Disclosure

SEC source: 0000950170-24-016574 · ownership.xml · nonDerivative · entry 2

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 194,428

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2023

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.40 to $80.25, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
February 15, 2024 Filed Feb 16, 2024 22:45 UTC
Kulkarni SamarthDirector · Chief Executive Officer
Exercise / conversionCommon Shares 20,000 $19.12 $382,400.00
Disclosure

SEC source: 0000950170-24-016574 · ownership.xml · nonDerivative · entry 1

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 207,377

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 29, 2024 Filed Jan 31, 2024 22:45 UTC
Kulkarni SamarthDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 50,000 Not disclosed Strike: $19.12 Not disclosed
Disclosure

SEC source: 0000950170-24-009505 · ownership.xml · derivative · entry 5

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Shares · 50,000 shares

Expires 2027-12-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · price: Not applicable.

F4 · derivative.exercise_date: This performance-based stock option was granted on December 1, 2017 with respect to 150,000 Common Shares and was subject to both time- and performance-based vesting. Performance-based stock options vested as to 112,500 options on December 1, 2020 and 37,500 options on December 1, 2021, based on the Company's performance over the applicable performance period, and subject to the terms and conditions of the agreement evidencing the award and the Company's 2016 Stock Option and Incentive Plan.

Read SEC document
January 29, 2024 Filed Jan 31, 2024 22:45 UTC
Kulkarni SamarthDirector · Chief Executive Officer
SaleCommon Shares 700 $61.10 $42,769.86
Disclosure

SEC source: 0000950170-24-009505 · ownership.xml · nonDerivative · entry 3

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 187,377

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2023

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.04 to $61.155, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
January 29, 2024 Filed Jan 31, 2024 22:45 UTC
Kulkarni SamarthDirector · Chief Executive Officer
SaleCommon Shares 49,300 $60.50 $2,982,802.83
Disclosure

SEC source: 0000950170-24-009505 · ownership.xml · nonDerivative · entry 2

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 188,077

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2023

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.04 to $61.02, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
January 29, 2024 Filed Jan 31, 2024 22:45 UTC
Kulkarni SamarthDirector · Chief Executive Officer
Exercise / conversionCommon Shares 50,000 $19.12 $956,000.00
Disclosure

SEC source: 0000950170-24-009505 · ownership.xml · nonDerivative · entry 1

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 237,377

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 16, 2024 Filed Jan 18, 2024 22:45 UTC
Kulkarni SamarthDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 20,000 $0.00 Strike: $19.12 $0.00
Disclosure

SEC source: 0000950170-24-005492 · ownership.xml · derivative · entry 4

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 59,582

Underlying: Common Shares · 20,000 shares

Expires 2027-12-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: This option was granted on December 1, 2017 with respect to 260,000 Common Shares with 100% of the shares vesting in 48 equal monthly installments beginning January 1, 2018.

Read SEC document
January 16, 2024 Filed Jan 18, 2024 22:45 UTC
Kulkarni SamarthDirector · Chief Executive Officer
SaleCommon Shares 20,000 $62.50 $1,250,058.00
Disclosure

SEC source: 0000950170-24-005492 · ownership.xml · nonDerivative · entry 2

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 187,377

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2023.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.2250 to $63.195, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
January 16, 2024 Filed Jan 18, 2024 22:45 UTC
Kulkarni SamarthDirector · Chief Executive Officer
Exercise / conversionCommon Shares 20,000 $19.12 $382,400.00
Disclosure

SEC source: 0000950170-24-005492 · ownership.xml · nonDerivative · entry 1

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 207,377

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: 200,000 common shares were recently transferred to The Kulkarni 2023 GRAT.

Read SEC document
October 13, 2023 Filed Oct 17, 2023 21:52 UTC
Prasad RajuChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 13,832 $0.00 Strike: $44.31 $0.00
Disclosure

SEC source: 0000950170-23-053820 · ownership.xml · derivative · entry 1

Prasad Raju · CIK 0001968317 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,832

Underlying: Common Shares · 13,832 shares

Expires 2033-10-13

F1 · derivative.exercise_date: This option was granted on October 13, 2023 with respect to 13,832 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of November 13, 2023.

Read SEC document
October 13, 2023 Filed Oct 17, 2023 21:52 UTC
Morrow Phuong KhanhChief Medical Officer
GrantStock Option (Right to Buy) · Derivative 16,667 $0.00 Strike: $44.31 $0.00
Disclosure

SEC source: 0000950170-23-053819 · ownership.xml · derivative · entry 1

Morrow Phuong Khanh · CIK 0001928989 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,667

Underlying: Common Shares · 16,667 shares

Expires 2033-10-13

F1 · derivative.exercise_date: This option was granted on October 13, 2023 with respect to 16,667 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of November 13, 2023.

Read SEC document
October 13, 2023 Filed Oct 17, 2023 21:51 UTC
Kulkarni SamarthDirector · Chief Executive Officer
GrantRestricted Stock Unit · Derivative 25,000 $0.00 $0.00
Disclosure

SEC source: 0000950170-23-053818 · ownership.xml · derivative · entry 2

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Shares · 25,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

F3 · derivative.exercise_date: This restricted stock unit award was granted on October 13, 2023 with respect to 25,000 Common Shares, with (i) one third of the shares vesting on October 13, 2024, (ii) one third of the shares vesting on October 13, 2025, and (iii) one third of the shares vesting on October 13, 2026.

F3 · derivative.expiration_date: This restricted stock unit award was granted on October 13, 2023 with respect to 25,000 Common Shares, with (i) one third of the shares vesting on October 13, 2024, (ii) one third of the shares vesting on October 13, 2025, and (iii) one third of the shares vesting on October 13, 2026.

Read SEC document
October 13, 2023 Filed Oct 17, 2023 21:51 UTC
Kulkarni SamarthDirector · Chief Executive Officer
GrantStock Option (Right to Buy) · Derivative 52,500 $0.00 Strike: $44.31 $0.00
Disclosure

SEC source: 0000950170-23-053818 · ownership.xml · derivative · entry 1

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,500

Underlying: Common Shares · 52,500 shares

Expires 2033-10-13

F1 · derivative.exercise_date: This option was granted on October 13, 2023 with respect to 52,500 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of November 13, 2023.

Read SEC document
October 13, 2023 Filed Oct 17, 2023 21:48 UTC
KASINGER JAMES R.General Counsel and Secretary
GrantRestricted Stock Units · Derivative 6,340 $0.00 $0.00
Disclosure

SEC source: 0000950170-23-053817 · ownership.xml · derivative · entry 2

KASINGER JAMES R. · CIK 0001708172 · General Counsel and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,340

Underlying: Common Shares · 6,340 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

F3 · derivative.exercise_date: This restricted stock unit award was granted on October 13, 2023 with respect to 6,340 Common Shares, with (i) one third of the shares vesting on October 13, 2024, (ii) one third of the shares vesting on October 13, 2025, and (iii) one third of the shares vesting on October 13, 2026.

F3 · derivative.expiration_date: This restricted stock unit award was granted on October 13, 2023 with respect to 6,340 Common Shares, with (i) one third of the shares vesting on October 13, 2024, (ii) one third of the shares vesting on October 13, 2025, and (iii) one third of the shares vesting on October 13, 2026.

Read SEC document
October 13, 2023 Filed Oct 17, 2023 21:48 UTC
KASINGER JAMES R.General Counsel and Secretary
GrantStock Option (Right to Buy) · Derivative 16,667 $0.00 Strike: $44.31 $0.00
Disclosure

SEC source: 0000950170-23-053817 · ownership.xml · derivative · entry 1

KASINGER JAMES R. · CIK 0001708172 · General Counsel and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,667

Underlying: Common Shares · 16,667 shares

Expires 2033-10-13

F1 · derivative.exercise_date: This option was granted on October 13, 2023 with respect to 16,667 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of November 13, 2023.

Read SEC document
June 08, 2023 Filed Jun 9, 2023 21:36 UTC GrantStock Option (Right to Buy) · Derivative 13,000 $0.00 Strike: $62.59 $0.00
Disclosure

SEC source: 0001209191-23-035980 · doc4.xml · derivative · entry 1

Treco Douglas A · CIK 0001688192 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,000

Underlying: Common Shares · 13,000 shares

Expires 2033-06-08

F1 · derivative.exercise_date: This option was granted on June 8, 2023 with respect to 13,000 Common Shares with 100% of the shares vesting in 12 equal monthly installments beginning on June 30, 2023; provided that the last installment will vest on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2024 Annual General Meeting of Shareholders.

Read SEC document
June 08, 2023 Filed Jun 9, 2023 21:56 UTC GrantStock Option (Right to Buy) · Derivative 13,000 $0.00 Strike: $62.59 $0.00
Disclosure

SEC source: 0001209191-23-035992 · doc4.xml · derivative · entry 1

George Simeon · CIK 0001595117 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,000

Underlying: Common Shares · 13,000 shares

Expires 2033-06-08

F1 · derivative.exercise_date: This option was granted on June 8, 2023 with respect to 13,000 Common Shares with 100% of the shares vesting in 12 equal monthly installments beginning on June 30, 2023; provided that the last installment will vest on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2024 Annual General Meeting of Shareholders.

Read SEC document
June 08, 2023 Filed Jun 9, 2023 21:48 UTC GrantStock Option (Right to Buy) · Derivative 13,000 $0.00 Strike: $62.59 $0.00
Disclosure

SEC source: 0001209191-23-035990 · doc4.xml · derivative · entry 1

Behbahani Ali · CIK 0001613867 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,000

Underlying: Common Shares · 13,000 shares

Expires 2033-06-08

F1 · derivative.exercise_date: This option was granted on June 8, 2023 with respect to 13,000 Common Shares with 100% of the shares vesting in 12 equal monthly installments beginning on June 30, 2023; provided that the last installment will vest on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2024 Annual General Meeting of Shareholders.

Read SEC document
June 08, 2023 Filed Jun 9, 2023 21:36 UTC GrantStock Option (Right to Buy) · Derivative 13,000 $0.00 Strike: $62.59 $0.00
Disclosure

SEC source: 0001209191-23-035978 · doc4.xml · derivative · entry 1

High Katherine A · CIK 0001631248 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,000

Underlying: Common Shares · 13,000 shares

Expires 2033-06-08

F1 · derivative.exercise_date: This option was granted on June 8, 2023 with respect to 13,000 Common Shares with 100% of the shares vesting in 12 equal monthly installments beginning on June 30, 2023; provided that the last installment will vest on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2024 Annual General Meeting of Shareholders.

Read SEC document
June 08, 2023 Filed Jun 9, 2023 21:34 UTC
Greene JohnDirector
GrantStock Option (Right to Buy) · Derivative 13,000 $0.00 Strike: $62.59 $0.00
Disclosure

SEC source: 0001209191-23-035977 · doc4.xml · derivative · entry 1

Greene John · CIK 0001610732 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,000

Underlying: Common Shares · 13,000 shares

Expires 2033-06-08

F1 · derivative.exercise_date: This option was granted on June 8, 2023 with respect to 13,000 Common Shares with 100% of the shares vesting in 12 equal monthly installments beginning on June 30, 2023; provided that the last installment will vest on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2024 Annual General Meeting of Shareholders.

Read SEC document
June 08, 2023 Filed Jun 9, 2023 21:34 UTC GrantStock Option (Right to Buy) · Derivative 13,000 $0.00 Strike: $62.59 $0.00
Disclosure

SEC source: 0001209191-23-035975 · doc4.xml · derivative · entry 1

Fleming Harold Edward · CIK 0001857250 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,000

Underlying: Common Shares · 13,000 shares

Expires 2033-06-08

F1 · derivative.exercise_date: This option was granted on June 8, 2023 with respect to 13,000 Common Shares with 100% of the shares vesting in 12 equal monthly installments beginning on June 30, 2023; provided that the last installment will vest on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2024 Annual General Meeting of Shareholders.

Read SEC document
June 08, 2023 Filed Jun 9, 2023 21:33 UTC
Fardis MariaDirector
GrantStock Option (Right to Buy) · Derivative 13,000 $0.00 Strike: $62.59 $0.00
Disclosure

SEC source: 0001209191-23-035974 · doc4.xml · derivative · entry 1

Fardis Maria · CIK 0001559231 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,000

Underlying: Common Shares · 13,000 shares

Expires 2033-06-08

F1 · derivative.exercise_date: This option was granted on June 8, 2023 with respect to 13,000 Common Shares with 100% of the shares vesting in 12 equal monthly installments beginning on June 30, 2023; provided that the last installment will vest on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2024 Annual General Meeting of Shareholders.

Read SEC document
May 30, 2023 Filed Jun 1, 2023 21:44 UTC
Kulkarni SamarthDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 25,000 $0.00 Strike: $19.12 $0.00
Disclosure

SEC source: 0001209191-23-033394 · doc4.xml · derivative · entry 6

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 79,582

Underlying: Common Shares · 25,000 shares

Expires 2027-12-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: This option was granted on December 1, 2017 with respect to 260,000 Common Shares with 100% of the shares vesting in 48 equal monthly installments beginning January 1, 2018.

Read SEC document
May 30, 2023 Filed Jun 1, 2023 21:44 UTC
Kulkarni SamarthDirector · Chief Executive Officer
SaleCommon Shares 2,400 $66.83 $160,401.12
Disclosure

SEC source: 0001209191-23-033394 · doc4.xml · nonDerivative · entry 5

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 387,377

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 26, 2022.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.15 to $66.76, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 30, 2023 Filed Jun 1, 2023 21:44 UTC
Kulkarni SamarthDirector · Chief Executive Officer
SaleCommon Shares 9,300 $65.63 $610,359.00
Disclosure

SEC source: 0001209191-23-033394 · doc4.xml · nonDerivative · entry 4

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 389,777

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 26, 2022.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.97 to $65.91, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 30, 2023 Filed Jun 1, 2023 21:44 UTC
Kulkarni SamarthDirector · Chief Executive Officer
SaleCommon Shares 5,999 $64.46 $386,681.74
Disclosure

SEC source: 0001209191-23-033394 · doc4.xml · nonDerivative · entry 3

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 399,077

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 26, 2022.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.97 to $64.89, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 30, 2023 Filed Jun 1, 2023 21:44 UTC
Kulkarni SamarthDirector · Chief Executive Officer
SaleCommon Shares 7,301 $63.61 $464,452.38
Disclosure

SEC source: 0001209191-23-033394 · doc4.xml · nonDerivative · entry 2

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 405,076

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 26, 2022.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.96 to $63.93, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 30, 2023 Filed Jun 1, 2023 21:44 UTC
Kulkarni SamarthDirector · Chief Executive Officer
Exercise / conversionCommon Shares 25,000 $19.12 $478,000.00
Disclosure

SEC source: 0001209191-23-033394 · doc4.xml · nonDerivative · entry 1

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 412,377

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 24, 2023 Filed May 25, 2023 21:35 UTC
Morrow Phuong KhanhChief Medical Officer
Tax withholdingCommon Shares 2,527 $65.91 $166,554.57
Disclosure

SEC source: 0001209191-23-032250 · doc4.xml · nonDerivative · entry 2

Morrow Phuong Khanh · CIK 0001928989 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,411

F3 · kind: On May 23, 2022, the reporting person was granted 27,750 restricted stock units. On May 23, 2023, 6,938 restricted stock units vested. Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person.

Read SEC document
May 23, 2023 Filed May 25, 2023 21:35 UTC
Morrow Phuong KhanhChief Medical Officer
Exercise / conversionRestricted Stock Units · Derivative 6,938 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-032250 · doc4.xml · derivative · entry 3

Morrow Phuong Khanh · CIK 0001928989 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,812

Underlying: Common Shares · 6,938 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

F2 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

F1 · derivative.exercise_date: The restriced stock units shall vest as follows: (i) one quarter of the shares shall vest on May 23, 2023, (ii) one quarter of the shares shall vest on May 23, 2024, (iii) one quarter of the shares shall vest on May 23, 2025, and (iv) one quarter of the shares shall vest on May 23, 2026.

F1 · derivative.expiration_date: The restriced stock units shall vest as follows: (i) one quarter of the shares shall vest on May 23, 2023, (ii) one quarter of the shares shall vest on May 23, 2024, (iii) one quarter of the shares shall vest on May 23, 2025, and (iv) one quarter of the shares shall vest on May 23, 2026.

Read SEC document
May 23, 2023 Filed May 25, 2023 21:35 UTC
Morrow Phuong KhanhChief Medical Officer
Exercise / conversionCommon Shares 6,938 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-032250 · doc4.xml · nonDerivative · entry 1

Morrow Phuong Khanh · CIK 0001928989 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,938

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The restriced stock units shall vest as follows: (i) one quarter of the shares shall vest on May 23, 2023, (ii) one quarter of the shares shall vest on May 23, 2024, (iii) one quarter of the shares shall vest on May 23, 2025, and (iv) one quarter of the shares shall vest on May 23, 2026.

F2 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

Read SEC document
April 25, 2023 Filed Apr 27, 2023 21:37 UTC
Kulkarni SamarthDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 25,000 $0.00 Strike: $19.12 $0.00
Disclosure

SEC source: 0001209191-23-025901 · doc4.xml · derivative · entry 4

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 104,582

Underlying: Common Shares · 25,000 shares

Expires 2027-12-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: This option was granted on December 1, 2017 with respect to 260,000 Common Shares with 100% of the shares vesting in 48 equal monthly installments beginning January 1, 2018.

Read SEC document
April 25, 2023 Filed Apr 27, 2023 21:37 UTC
Kulkarni SamarthDirector · Chief Executive Officer
SaleCommon Shares 4,393 $51.45 $226,021.17
Disclosure

SEC source: 0001209191-23-025901 · doc4.xml · nonDerivative · entry 3

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 387,377

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 26, 2022.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.17 to $51.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
April 25, 2023 Filed Apr 27, 2023 21:37 UTC
Kulkarni SamarthDirector · Chief Executive Officer
SaleCommon Shares 20,607 $50.50 $1,040,616.41
Disclosure

SEC source: 0001209191-23-025901 · doc4.xml · nonDerivative · entry 2

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 391,770

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 26, 2022.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.17 to $51.165, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
April 25, 2023 Filed Apr 27, 2023 21:37 UTC
Kulkarni SamarthDirector · Chief Executive Officer
Exercise / conversionCommon Shares 25,000 $19.12 $478,000.00
Disclosure

SEC source: 0001209191-23-025901 · doc4.xml · nonDerivative · entry 1

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 412,377

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 29, 2023 Filed Mar 31, 2023 21:49 UTC
Kulkarni SamarthDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 25,000 $0.00 Strike: $19.12 $0.00
Disclosure

SEC source: 0001209191-23-021911 · doc4.xml · derivative · entry 4

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 129,582

Underlying: Common Shares · 25,000 shares

Expires 2027-12-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: This option was granted on December 1, 2017 with respect to 260,000 Common Shares with 100% of the shares vesting in 48 equal monthly installments beginning January 1, 2018.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.